--- title: "Oncology Generics Medicines" ocid: "ocds-r6ebe6-0000554396" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000554396" markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000554396.md" json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000554396.json" source: "Public Contracts Scotland" current_stage: "Award" buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")" published: "2019-01-24" --- # Oncology Generics Medicines Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") Current stage: Award OCID: ocds-r6ebe6-0000554396 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000554396) [Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000554396.json) ## Summary The Common Services Agency, also known as NHS National Services Scotland, is conducting a procurement process for "Oncology Generics Medicines" aimed at supplying a range of Oncology Generic Medicines to Health Boards across NHS Scotland. This open tender, initiated on 25th September 2018, is currently at the active stage and includes 37 lots for various medicinal products, with the deadline for submissions set for 29th October 2018 at 12:00. The contract will be awarded based on quality and price, and suppliers are encouraged to bid for multiple lots. Participating in this procurement process offers significant opportunities for pharmaceutical companies, particularly those specialising in oncology products. The framework agreement, which allows for a maximum of 24 months extension, will enable suppliers to establish or grow their business within Scotland's health sector. Businesses with existing UK Marketing Authorisations and certifications such as ISO 9001 will be well-positioned to compete effectively in this tender. ## Notice Supply of Oncology Generic Medicines to Health Boards across NHS Scotland ### Lot Information Lot 1 Bendamustine Powder For Solution For Infusion Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 2 Capecitabine Tablets Supply of Capecitabine Tablets to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 3 Carboplatin Injection Supply of Carboplatin Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 4 Cisplatin Injection Supply of Cisplatin Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 5 Cyclophosphamide Injection, Powder For Reconstitution Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 6 Cytarabine Injections Supply of Cytarabine Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 7 Dacarbazine Injections Supply of Dacarbazine Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 8 Disodium Folinate Injection Supply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 9 Docetaxel Concentrate For Solution For Infusion Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 10 Doxorubicin Hydrochloride Injections Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 11 Imatinib The supply of Imatinib to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier award. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 12 Etoposide Injection Supply of Etoposide Injection to NHS Scotland.The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 13 Fluorouracil 25MG/ML Injection Supply of Fluorouracil 25MG/ML Injections to NHS Scotland. This Lot has not been awarded. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 14 Fluorouracil 50MG/ML Injection Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 15 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 16 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 17 Gemcitabine Powder For Solution For Infusion Vials Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 18 Idarubicin Hydrochlioride Injection Powder For Reconstitution Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 19 Ifosfamide Injection Powder For Reconstitution Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 20 Irinotecan Hydrochloride Injection Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 21 Lanreotide Injection Prefilled Syringes Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 22 Methotrexate Without Preservatives Injection Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 23 Methotrexate Oral Solution Supply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 24 Mitomycin Injection Powder For Reconstitution Supply of Mitomycin Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 25 Octreotide Injection Supply of Octreotide Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 26 Oxaliplatin Vial Solution Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 27 Paclitaxel Concentrate For Intravenous Infusion Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 28 Dasatinib Supply of Dasatinib to NHS Scotland This Lot has not been awarded. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 29 Aprepitant Supply of Aprepitant to NHS Scotland This Lot has not been awarded. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 30 Temozolomide Capsules Supply of Temozolomide Capsules to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 31 Topotecan Capsules Supply of Topotecan Capsules to NHS Scotland. This Lot has not been awarded. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 32 Topotecan Concentrate For Solution For Infusion Supply of Topotecan Concentrate For Solution For Infusion to NHS Scotland. This Lot has not been awarded. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 33 Vincristine Without Preservatives Injection Supply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 36 Everolimus Supply of Everolimus to NHS Scotland. This Lot has not been awarded. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 37 All Other Oncology Generic Products/Presentations The supply of All Other Oncology Generic Products/Presentations to NHS Scotland. Each product line was treated as an individual lot and awarded to a single supplier for the full lot. The Authority has awarded this Lot to 20 suppliers. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 34 Vinorelbine Injection Supply of Vinorelbine Injections to NHS Scotland. The Authority has awarded this Lot to a single supplier. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). Lot 35 Vinorelbine Capsules Supply of Vinorelbine Capsules to NHS Scotland. This Lot has not been awarded. Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s). ## Key Details | Field | Value | | --- | --- | | Publication source | Public Contracts Scotland | | Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN343204 | | Notice type | OJEU - F3 - Contract Award Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 24 Jan 2019 | | Submission deadline | 29 Oct 2018 | | Future notice date | Not specified | | Award date | 24 Dec 2018 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | £36,587,145 | | Awards value | Not specified | | Contracts value | £18,742,949 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Complete | | Awards status | Unsuccessful | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") | | Locality | EDINBURGH | | Post town | Edinburgh | | Postcode | EH12 9EB | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM1 East Central Scotland | | ITL 3 | TLM13 City of Edinburgh | | Local authority | City of Edinburgh | | Electoral ward | Drum Brae/Gyle | | Westminster constituency | Edinburgh South West | | Delivery location | TLM Scotland | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 23 | | Supplier names | ACCORD HEALTHCARE; AVENTIS PHARMA LTD TRADING AS SANOFI; BAXTER HEALTHCARE; CONSILIENT HEALTH; FRESENIUS KABI; GLENMARK PHARMACEUTICALS EUROPE; INTRAPHARM LABORATORIES; IPSEN; KENT PHARMACEUTICALS; KYOWA KIRIN; MARTINDALE PHARMA; MEDAC; MERCURY PHARMA GROUP; MORNINGSIDE PHARMACEUTICALS; NOVARTIS PHARMACEUTICALS; PFIZER; RANBAXY; ROSEMONT PHARMACEUTICALS; SANDOZ; SELECTIVE SUPPLIES; TEVA; TILLOMED LABORATORIES; ZENTIVA PHARMA | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 24 Jan 2019 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN343204 - 25 Sep 2018 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP332429 ## Documents - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP332429 Oncology Generics Medicines - This Framework Agreement is for the supply of a range of Oncology Generic Medicines to NHS Scotland, which will be awarded on a product line or lot by lot basis. As detailed below this framework is tendered using 37 Lots Lots 1-36 (except 11, 28 & 36) - All of the product lines included within each Lot will be grouped together as individual Lots and awarded to a single Framework Participant per Lot. Lots 11, 28 & 36 - Each product line will be treated as an individual Lot and be awarded on a line by line basis. Each Lot will be awarded as a ranked multi-supplier framework to an envisaged maximum of 6 Framework Participants per line. Lot 37 - Each product line within Lot 37 will be treated as an individual Lot and awarded to a single Framework Participant. Tenderers are invited to bid for as many Lots/lines as they wish. The individual descriptions and quantities are detailed within the tender documentation. - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN343204 Oncology Generics Medicines - Supply of Oncology Generic Medicines to Health Boards across NHS Scotland ## Notice URLs - http:// - http://www.nhsscotlandprocurement.scot.nhs.uk/ - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000554396 - https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000554396. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000554396.json.